星湖科技(600866) - 2021 Q2 - 季度财报

Financial Performance - The company's operating revenue for the first half of 2021 was approximately ¥581.05 million, a decrease of 0.71% compared to the same period last year[21]. - The net profit attributable to shareholders for the first half of 2021 was approximately ¥76.03 million, down 9.11% year-on-year[21]. - Basic earnings per share for the first half of 2021 were ¥0.1029, a decrease of 9.10% compared to the same period last year[22]. - The company's gross profit margin was impacted by a 10.28% increase in operating costs, driven by a more than 40% rise in the prices of key raw materials like corn starch[33]. - The company reported a significant reduction in selling expenses by 67.55% to CNY 3.98 million, mainly due to decreased employee compensation and promotional costs[32]. - The total profit for the first half of 2021 was CNY 79,763,270.68, a decrease of 8.0% compared to CNY 87,531,531.48 in the same period of 2020[145]. - The net profit for the first half of 2021 was CNY 76,026,584.77, a decrease of 9.2% compared to CNY 83,646,752.37 in the first half of 2020[145]. Cash Flow and Financial Position - The net cash flow from operating activities significantly decreased by 93.74%, amounting to approximately ¥6.02 million[21]. - The net cash flow from financing activities increased by 103.34% to CNY 81.25 million, attributed to increased bank loans for project financing[33]. - The company’s cash and cash equivalents decreased to CNY 215,867,228.02 from CNY 232,550,236.41, a decline of approximately 7.2%[131]. - The cash flow from operating activities generated a net amount of ¥6.02 million, a decrease of 93.7% compared to ¥96.16 million in the same period last year[153]. - The total assets at the end of the reporting period were approximately ¥2.55 billion, an increase of 5.09% compared to the end of the previous year[21]. - Total current assets as of June 30, 2021, amounted to CNY 848,351,167.65, an increase from CNY 726,024,447.79 as of December 31, 2020, reflecting a growth of approximately 16.8%[131]. Investments and Subsidiaries - The health industry subsidiary, established with a registered capital of 50 million RMB, has total assets of 46.79 million RMB but reported a net loss of 699,000 RMB in the first half of 2021[46]. - Jiu Ling Pharmaceutical, fully owned by the company, achieved a revenue of 80.07 million RMB in the first half of 2021, contributing 13.78% to the company's total revenue, with a net profit of 1.76 million RMB, accounting for 23.12% of the company's net profit[46]. - The company has invested a total of 5.81 billion RMB in the first phase of the Zhaodong Bio-fermentation Industrial Park, with a planned investment not exceeding 6.8 billion RMB, and the project is now in trial production[44]. - The company has established a new subsidiary focused on health products, indicating a strategic expansion into the health sector[44]. Environmental Compliance - The company maintains a 100% operational rate for its environmental protection facilities, ensuring compliance with national standards[64]. - The company’s biological engineering base and pharmaceutical plants are classified as key pollution sources, with emissions consistently meeting industry and national standards[60]. - The company has established emergency response plans for environmental incidents, which have been filed with local environmental authorities[66]. - During the reporting period, the company faced administrative penalties totaling CNY 96.49 million due to environmental issues, including CNY 26.37 million for improper wastewater disposal and CNY 58 million for premature production without completed environmental facilities[71]. Strategic Decisions and Changes - The company did not propose any profit distribution plan or capital reserve transfer to share capital during the reporting period[6]. - The company has terminated the investment contract for the green health industry park, reflecting a strategic decision to withdraw from that project[44]. - Two directors, Chen Zhipeng and Xu Rongdan, resigned due to work adjustments, while Wang Li and Pang Bixia were elected as new directors[55]. - The company has initiated a lawsuit regarding patent infringement, which could result in significant financial implications if the court rules against it, with potential damages amounting to 20 million RMB[50]. Shareholder Information - The total number of shares before the change was 739,019,166, with 97.74% being unrestricted shares[113]. - The company issued 16,665,955 new shares during the reporting period, resulting in a total of 739,019,166 shares after the change[113]. - The number of shareholders reached 47,613 by the end of the reporting period[119]. - Guangdong Province Guangxin Holdings Group Co., Ltd. held 134,642,420 shares, representing 18.22% of total shares[119]. Research and Development - Research and development expenses increased by 51.91% to CNY 31.65 million, reflecting the company's commitment to product development[32]. - Research and development expenses increased to ¥15.40 million, up 37.8% from ¥11.21 million in the previous year, indicating a focus on innovation[149]. Risk Management - The company has detailed potential risks in the report, which investors should be aware of[7]. - The company faces risks related to production costs and price fluctuations, particularly due to reliance on corn starch as a primary raw material[50].